SCHEDULE 13D OF MEIR DUKE

Company

Raphael Pharmaceutical Inc.

Filed

April 16, 2008

Accession Number

0001165527-08-000208

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →